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Abstract
Since 1978 when the first “petri dish” baby was born, In-Vitro Fertilization (IVF) has been used as a tool to give couples struggling 
with infertility the opportunity to have children . Using this method of Assisted Reproductive Technology (ART), the woman is given 
medication to stimulate her ovaries for the maturation of multiple eggs, which are then retrieved via needle aspiration, fertilized 
in a petri dish, and inserted in the uterus with the hopes of achieving a successful pregnancy . Many times IVF is completed with 
another technique known as Intracytoplasmic Sperm Injection (ICSI), where the sperm is injected straight into the egg increasing 
the chance of fertilization . In 2002, researchers discovered a clear association between an increased risk for birth defects with 
the use of In-Vitro Fertilization and Intracytoplasmic Sperm Injection . Since then, multiple studies were conducted to determine 
whether it is instigated by a mechanism of IVF itself, or influenced by the infertility problems of the couple (Hansen et al., 2002). 
There are various reasonable explanations for the findings of the surfeit occurrence of birth defects in pregnancies with use of 
IVF or ICSI . Firstly, the advanced age of couples undergoing infertility treatments could be the basis for the underlying increase in 
birth defects . Maternal factors such as obesity, metabolic disease, and chronic health issues are independent factors proven to 
increase the risk for birth defects as well (Davies MJ et al ., 2012) . Factors associated with the treatment such as, freezing and 
thawing of embryos, exposure of oocytes or embryos to a culture medium, or ICSI gamete manipulation, could also contribute 
Additional explanations point to the medications given to induce follicular numbers, or to speed the maturation of follicles into 
oocytes (Hansen et al ., 2002) .  This paper reviews numerous studies that have been done to resolve the question at hand . 
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Introduction 
Infertility
Intervention with medical assistance is required for one in ten 
couples who have difficulty conceiving naturally. Conception is 
a complex process that requires many factors to be working in 
synchrony to develop into a successful pregnancy. The problem 
can be attributed to female or male components. After one year 
without conceiving, couples are referred to a specialist to deter-
mine the root of the infertility. When the woman is over the age 
of 35, they are advised to seek medical advice after six months 
without conceiving. The most common causes of female infertil-
ity are irregular ovulation, obstructed fallopian tubes or, congen-
ital anomalies of the uterus. Male infertility is most often caused 
by azoospermia, when no sperm is produced, or oligospermia, 
too few sperm. When faced with any of these factors, Assisted 
Reproductive Technology may be required.
In-Vitro Fertilization Process
The first step in the process of IVF is to produce ovarian hy-
perstimulation by giving medications to stimulate egg production. 
Injections of gonadotropins are given daily until multiple follicles 
develop into optimal size. Next, Human Chorionic Gonadotropin 
(HCG) is administered to speed the maturation of the follicles 
into oocytes. The eggs are then retrieved via needle aspiration 
using transvaginal ultrasonography and stored in a special culture 
medium until insemination. In a case with normal sperm, 50,000 
to 100,000 motile sperm/ml are transferred into the petri dish 
with the mature eggs. When quality of the sperm is abnormal, 
such as poor motility or morphology, intracytoplasmic sperm in-
jection (ICSI) is used to fertilize the egg. During ICSI, an embryol-
ogist uses a micro needle to inject one single sperm directly into 
the egg cytoplasm. After insemination, the embryo or embryos 
are placed in a catheter and injected into the endometrium in 
hopes of implanting onto the uterine wall (Wdowiak et. al. 2016). 
Cultured embryos often have difficulty exiting from the zona 
pellucida membrane. Artificial disruption using laser perforation 
may be required to aid in the process and increase the chance of 
implantation (Zakharchenko et al., 2015). 
Methods
The research discussed in this paper was compiled from var-
ious published articles taken from Touro’s database, including, 
Proquest Science, EBSCO, PubMed, and Google Scholar. All 
articles are original scientific papers that were analyzed and 
explored to obtain accurate data.
Discussion 
IVF & Birth Defects
Researchers wondered whether the process of Assisted 
Reproductive Technologies, specifically IVF, can affect the risk of 
congenital birth defects, or developmental delays. Investigators 
used data from The Reproductive Technology Register in 
Western Australia, to analyze pregnancies between the years 
1993 to1997, that were a product of IVF or ICSI. They surveyed 
all pregnancies that reached 20 weeks and were terminated 
because of fetal abnormalities. The Western Australian Birth 
Defects Registry listed all of the birth defects in pregnancies 
in Western Australia, from natural pregnancies and pregnancies 
that required the use of ART. With the data from these two in-
stitutions, researchers examined all pregnancies that were ter-
minated, stillborn, or live births during these years, to determine 
whether birth defects were more common in infants conceived 
with use of IVF or ICSI. The presence of major birth defects 
diagnosed until the age of one year was examined.
There were a total of 168 out of 4000 infants conceived nat-
urally, 75 out of 837 conceived via IVF, and 26 out of 301 from 
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ICSI, that were diagnosed with birth defects before the age of 
one year. The authors reported that the risk of birth defects 
was twofold in pregnancies that required Assisted Reproductive 
Technology. The results remained significant when only single-
ton births and full term births were taken into consideration. 
Other studies attribute the increase in risk of birth defects to 
the multiple births and preterm births that often are associated 
with use of ART. This research restricted the analysis to single-
ton and full term births so the results would not be explained 
by these factors. The overall risks remained the same when 
factors such as, maternal age and parity, sex of the infant, and 
association of siblings with birth defects, were taken into con-
sideration. Furthermore, when analyzing the prevalence of birth 
defects in terminated pregnancies, the results remained similar 
to the original analyses. The prevalence of birth defects in ter-
minated pregnancies was 4.5% in natural conception, 9.4% with 
use of IVF, and 8.6% in the ICSI category (Hansen et al., 2002). 
After use of IVF the most commonly seen birth defects were 
cardiovascular, musculoskeletal, urogenital, gastrointestinal ab-
normalities and cerebral palsy. Also seen was an increased risk 
for multiple birth defects in singleton births specifically in the 
areas of cardiovascular defects, musculoskeletal, urogenital and 
cerebral palsy. The risk of respiratory disorders increased in 
cases of multiple births brought about by IVF. No association 
of increased risk in trisomy’s, such as Down’s, Edward’s and 
Turner’s was found (Davies et al., 2012). 
Parental Factors
Factors related to maternal and paternal age and health were 
examined to find reliable information on the association of birth 
defects and parental issues. A study was done examining the oc-
currence of birth defects diagnosed before age five and includ-
ing pregnancies that were terminated at any gestational age. The 
risks of birth defects were compared in pregnancies that were 
spontaneous versus assisted conception. Additional data was 
analyzed in women who reported infertility but eventually be-
came pregnant without the use of ART. With this information it 
can be determined whether infertility is the major factor in the 
cause of birth defects or if the technology is to blame. A total of 
308,974 births was used for analysis. The risk of birth defects in-
creased significantly in pregnancies of women who experienced 
a history of infertility but were not treated with ART, versus 
spontaneous pregnancies without history of infertility. This indi-
cates that the association of birth defects may be attributed to 
the patients’ medical factors rather than the IVF. On the other 
hand, some patients use treatments such as clomiphene citrate 
which is given outside the clinic and data on who used this med-
ication is not available for analyses. Clomiphene citrate is used 
for women experiencing anovulatory infertility to stimulate an 
increase in estrogen, a hormone that supports the growth of 
oocytes. This treatment could be the sole reason for increase 
in birth defects without use of IVF treatments, and may explain 
why women with a history of infertility had children with birth 
defects more commonly (Davies et al., 2012). Another study 
was done examining the mental health of children born to infer-
tile women who conceived spontaneously. The study indicated 
that there was a significantly higher increase in mental disorders 
such as schizophrenia, mood disorders, and psychological devel-
opment compared to children born to women without fertility 
problems (Svahn et al., 2015).
Another study was done to examine the degree at which 
maternal health issues were related to the increase in birth 
defects after IVF and ICSI. The South Australian Birth Defects 
Register contained all of the data on maternal medical condi-
tions following various fertility treatments. The maternal factors 
that were considered were maternal age at delivery, parity, BMI, 
smoking habits, hypertension, diabetes, asthma, epilepsy, and 
gestational conditions such as, pre-eclampsia, impaired glucose 
tolerance, gestational diabetes, anemia, and UTI occurrences. 
With regard to health conditions, only smoking and obesity 
were linked to an increase in the risk for birth defects over the 
general population risk. With regard to ICSI, parity, anemia, and 
UTI occurrence, were also associated with an increase in birth 
defects. Additionally, the report indicated that the women with 
the greatest risk for an increase in birth defects with use of IVF 
were aged 29 and younger compared to fertile women of their 
age. The study suggests that the uterine environment of younger 
women is more likely to be able to sustain an embryo with birth 
defects or, the implantation success in older women is limited 
which helps to prevent developmentally compromised embryos 
from implanting. Women aged 40 and older were at a lesser risk 
for an increase in birth defects compared to fertile women of 
their age. A possible explanation may be the influence of the 
gonadotropins that may protect oocyte development (Davies 
MJ et al., 2012). 
Paternal factors also add to the increased risk for birth de-
fects with use of ART. According to one study, children born to 
fathers over the age of 40 are at an increased risk for childhood 
fatality due to congenital abnormalities and malignancies. When 
paternal age increased to over 45, the childhood fatality rate 
increased from 1.24% to 1.65% compared to fathers aged 30 
to 34 (Urhoj et al., 2014). When the sperm of infertile men 
was analyzed under light microscopy, it was noticed that there 
was an excess of DNA damaged sperm. DNA damage limits the 
ability of apoptosis to occur. Typically, apoptosis removes the 
damaged sperm but with IVF, fertilization can take place with 
damaged sperm that would have been excluded in natural con-
ception. This increases the risk for miscarriage and birth defects 
(Lewis & Kumar, 2015). Additionally, men with reproductive is-
sues often require the use of ICSI because of the poor motility 
and morphology of their sperm. ICSI can be problematic when 
abnormal sperm is inadvertently injected, or the injection itself 
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could damage the chromosome spindle formation in the oocyte 
(Winston & Handyside, 1993).
Multiple studies imply that the increase in birth defects or 
mental disorders with use of IVF is likely associated with pa-
rental factors. One study pointed to alternative treatments that 
may be used in addition to IVF. Overall, parental issues play a 
large role in the increase in birth defects with use of ART, al-
though there are other factors that are likely associated as well.
Cryopreservation
Cryopreservation involves preservation of an embryo or oo-
cyte in liquid nitrogen after cooling the sample in a cryopro-
tectant to -30 degrees Celsius (Winston & Handyside, 1993). 
The two methods for cryopreservation are slow freezing and 
vitrification. Currently, vitrification is the preferred method as it 
instantly solidifies the samples preventing the formation of ice 
crystals causing less damage to the oocytes or embryos. Slow 
freezing involves the use of a less toxic concentration of cryo-
protectants however, the limited ability to prevent ice crystals is 
thought to increase the risk for abnormalities.
There are severe problems involved in oocyte cryopreserva-
tion which is a common practice used for women approaching 
advanced maternal age. First, oocytes are temperature sensitive 
due to the high content of cytoplasmic liquid and, the arrange-
ment of the chromosomes in the sensitive spindle formation. 
Disruptions during the freezing and thawing process lead to a 
threefold increase in aneuploidy when spindle formation is dis-
turbed. The risk of polyploidy also increases, as frozen oocytes 
are more vulnerable to polyspermic fertilization when the corti-
cal granules are unevenly distributed (Jiminez- Trigos et al., 2012). 
Caution must be taken with these results because most studies 
are done on mice and the effect of chromosomal segregation is 
different between species. Additionally, cryopreservation of oo-
cytes reduces successful fertilization by inducing changes in the 
zona pellucida specifically, zona hardening, and, producing chang-
es on the sperm receptors of the zona (Winston & Handyside, 
1993). Data on the results of cryopreserved oocytes is limited 
as the number of births resulting from this technique is small. 
Further results on the health status of children born afterwards 
is not yet available, however reports do not indicate an increase 
in birth defects or developmental delays (Schattman, 2015). Some 
reports reveal that oocytes that developed in vitro have a de-
creased live births and pregnancy rates.
By analyzing the effect of vitrification on the oocyte, it can be 
determined if this technique causes adverse effects to oocyte 
functionality. The mitochondrial function of vitrified oocytes 
was observed by analyzing the condition of ATP synthase in the 
oocytes. ATP synthase in Metaphase II stage was analyzed by 
looking at the ratio of FAD to NAD(P)H. If the ratio is abnor-
mally elevated, it insinuates a decrease in the ATP synthase func-
tion of the oocytes which results in abnormal spindle formation. 
Additionally, the stage at which the oocytes are vitrified effects 
the outcomes. Vitirification can be performed at the Metaphase 
II stage which contains sensitive spindle formation, or the germi-
nal vesical stage, before the spindle is formed. The germinal vesi-
cle stage has to go through maturation after thawing which may 
also effect the value of the oocyte.  Live births have been seen 
from vitrification at both of these stages and it is not yet known 
which has a better success rate (Gao et al., 2017). Ultimately, the 
ideal method for freezing oocytes is not yet known, and it has 
been shown to increase the risk for aneuploidy or polyploidy, 
and decrease risk for fertilization. However, cryopreservation 
of oocytes is an opportunity for women who wish to preserve 
eggs for future use because of medical or age related issues. It 
is currently the only option to preserve fertility for women un-
dergoing treatments such as radiation or chemotherapy which 
may affect their ability to conceive. 
The transfer of frozen embryos has been used more fre-
quently in the past few decades as it has shown several advan-
tages. Multiple studies show that using frozen-embryo transfers 
increases the rate of live births compared to fresh-embryo 
transfers. Most reports point to the non-stimulated menstrual 
cycle that is associated with frozen transfers. When fresh-em-
bryos are transferred, the artificial hormone induced menstrual 
cycle adversely effects the endometrial receptivity leading to 
implantation failure (Aflatoonian et al., 2016). Studies have been 
done to determine differences noted between fresh-embryo 
and frozen-embryo transfers. A study of, 1508 infertile women 
diagnosed with Polycystic Ovarian Syndrome and were under-
going their first IVF treatment, were randomized in two groups. 
They received either fresh-embryo or frozen-embryo transfers. 
The women were all between the ages 20 to 34 and were in a 
healthy weight range. All patients went through the standard IVF 
procedure and subsequently a transfer of up to 2, day-3 embry-
os. The frequency of live births was considerably higher after 
the frozen-embryo transfers. The rates showed a 49.3% versus 
42% difference. It was proposed that when frozen-embryos are 
transferred, it allows time for the reproductive system to re-
cover from the induced ovulation by hormones. The exposed 
endometrial lining has time to shed, increasing the chance that 
the embryo will implant. The results may not be pertinent to 
the overall population undergoing IVF since these subjects were 
PCOS patients. Another study was done to assess whether in-
fertile women without Polycystic Ovarian Syndrome who were 
undergoing IVF showed the same results. The same method was 
used and in this case, the transfer of frozen embryos did not 
increase the chances for a higher live birth rate. Reasons for 
the different results may be due to the method of cryopreser-
vation or the timing of the freezing (Vuong et al., 2018).  In both 
studies no increase in the risk for congenital malformations was 
noticed (Zi-Jiang et al., 2016). Other studies note, that when 
comparing the risk of birth defects in the fresh-embryo and 
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frozen-embryo cycles, there was a significant increase in the 
risk of birth defects for the former.  Plausible justifications may 
be related to the cryopreservation that would eliminate the 
developmentally compromised embryos, because they would be 
less likely to survive the freezing and thawing process. Additional 
explanations that would eliminate the inferior embryos would 
be the separation of the embryo from hormonal stimulation 
drugs (Davies et al., 2012).
Various researchers have attempted to observe the effects of 
the cryopreservation process and the health status of the re-
sulting children. Most studies were done involving results from 
single-center analyses. A multi-center study between the period 
of 1995 to 2013 was done to analyze the miscarriage rates, birth 
weight, pregnancy complications and congenital malformations 
in IVF centers worldwide. It was determined that the subopti-
mal results were more likely caused by parental factors such as 
advanced age, concurrent metabolic, genetic and epigenetic al-
terations, which affects the health of gametes (Keshishian, 2014). 
After much research into the matter, the consensus appears to 
be that there is an increase in live birth rates after the use of 
frozen-embryo transfers although the reason is still unknown. It is 
most likely from the natural exclusion of unfit embryos during the 
freezing process, or the separation of the embryo from hormonal 
drugs giving the uterus time to readjust for the implantation pro-
cess. The presence of birth defects does not seem be affected by 
the freezing process and is more likely associated with parental 
issues. This interpretation is consistent with the majority of stud-
ies done to analyze the effects of embryo cryopreservation. 
Although cryopreservation of embryos is associated with an 
increase of pregnancy rates and a decrease in preterm labor, it is 
important to determine that there are no long term unforeseen 
consequences with regard to this technique. National registries in 
Denmark were used to examine the intellectual abilities of chil-
dren aged 15 to 16 born from cryopreserved embryos. A stan-
dardized test was given to all children ages 15 to 16 and overall 
test scores were evaluated. No apparent difference in the test 
scores between children conceived via IVF, fresh or frozen, and 
natural conception, was noticed. The study was limited as they 
did not observe the children that did not enter the school system 
due to intellectual disabilities (Spangmose et al., 2019)
Culture Medium
Fertilization normally takes place in a protected well-controlled 
setting in the oviduct. During IVF, the male and female gametes 
are brought together in a medium that is intended to provide 
conditions for the sperm to go through the process of capac-
itation and produce acrosome reactions, in order for sperm 
penetration, fertilization, and cleavage to occur (Bavister, 1981). 
Studies done on mouse embryos show that different conditions 
in the culture can lead to changes in gene expression. Good 
quality human day 4 cryopreserved embryos were donated to 
observe the effect of culture media on transcription. The embry-
os were randomly selected to be cultured in one of two media 
(HTF or G5) and one of two oxygen levels. The two media used 
were Human Tubal Fluid mixed with glucose and phosphate, and 
the second, a more enriched version of the medium contain-
ing additives such as additional amino acids (G5). The two HTF 
cultures and two G5 cultures contained either 5% or 20% ox-
ygen levels. The embryos were also classified for maternal age 
and developmental stage at the time of transfer. After culturing, 
89 embryos were transferred to PCR and further analyzed. 
Microarray data analysis was used to observe any correlation 
between differentially expressed genes (DEG’s), the upregula-
tion or downregulation of genes, and whether they were caused 
by different culture conditions, or whether biological factors 
such as maternal age and developmental stage played a larger 
role. The number of differentially expressed genes was signifi-
cantly higher with regard to biological factors when comparing 
it with the differentially expressed genes from different culture 
conditions. Notwithstanding the conviction that maternal age 
only effects oocytes, this data indicates that maternal age and 
developmental stage has a much greater effect on transcription. 
Although the correlation between transcription errors and cul-
ture conditions was minimal, it was noted that human embryos 
developed best in the G5 5% oxygen level culture medium. G5 
medium caused an upregulation in genes involved in regulation 
of phosphorylation and mitosis, and the lower oxygen level 
led to an upregulation of genes involved in cell morphogenesis 
which aids in embryo development (Mantikou et al., 2016).
Intravaginal culture (IVC), also known as INVO, is an ART 
technique where oocytes and early embryos are cultured in a 
gas permeable air-free plastic device placed in the vaginal cavity 
for incubation. The advantages are that INVO mimics the envi-
ronment of the uterus and excludes of use of a culture medium 
to sustain the fertilization and early growth of the embryo. IVF 
involves the use of a culture medium which influences embryo 
quality with changes in oxygen and carbon dioxide concentra-
tions, and, PH or temperature changes. If any of these factors be-
come unproportional, embryo fragmentation can occur. Oxygen 
in the uterine cavity is less than 5%. The INVO device is able 
to offer an environment similar in that way. The almost anaer-
obic oxygen concentration level guarantees a safe atmosphere 
for the energetic metabolism required for successful gamete 
viability, fertilization and embryo development. Carbon dioxide 
is another important factor involved in embryo development 
as it directly effects PH levels (Lucena et al., 2012). The INVO 
device is absorbent to gas in the uterus and allows for a bal-
anced equilibrium of CO2 to uphold the PH level of 7.2 to 7.4 
(Garcia-Ferreyra et al., 2015). On the other hand, in traditional 
IVF, the concentration of carbon dioxide can be altered when 
the large gas-filled incubators are opened. This effects the PH 
equilibrium and temperature of the culture medium, decreasing 
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embryo quality. A study was done to assess the outcomes of 
INVO and compare the pregnancy results to common existing 
IVF techniques (Lucena et al., 2012). Embryos were cultured in 
the INVO device and then transferred to the uterus on day 3 or 
day 5 after fertilization. The implantation rates, pregnancy rates, 
and miscarriage rates were considered. The results showed that 
the INVO-ICSI procedure had similar outcomes to the tradi-
tional IVF-ICSI procedure. Pregnancies were evaluated 14 days 
after embryo transfer by measuring hCG-beta subunits in the 
blood, and ultrasounds were utilized to reveal gestational sacs, 
and heartbeats 21 to 28 days after the transfer. INVO-ICSI was 
concluded to be alternative option for couples struggling with 
infertility, with advantages in cost effectiveness, and psycholog-
ical benefits, allowing a more direct involvement in fertilization 
which was shown to reduce stress levels in patients (Garcia-
Ferreyra et al., 2015). 
Another study was done to assess the effect of culture con-
ditions on Imprinting Disorders. Syndromes, such as, Angelman 
Syndrome, Beckwith- Wiedmann Syndrome, and Silver-Russel 
Syndrome, were found to be more prevalent after IVF. These syn-
dromes are referred to as genomic imprinting disorders and are 
an epigenetic phenomenon that restricts the expression of one 
parental allele leading to activation of only one copy of a chromo-
some. Imprinting genes are controlled by the Imprinting Control 
Region (ICR) where abnormal cytosine methylation occurs on 
various genes causing them to deactivate. A study was done that 
observed the methylation levels of ART produced human em-
bryos at day 3 of cleavage and the blastocyst stage. The specific 
ICRs analyzed were KCNQ1OT1, SNRPN, and H19, which are 
the ICR regions where most maternal methylation occurs in the 
syndromes studied. In the Beckwith-Wiedmann Syndrome chil-
dren conceived with ART, there were 90% observed methylation 
errors at KCNQ1OT1 as compared with 50% in the general pop-
ulation of cases with Beckwith-Wiedmann Syndrome. SNRPN 
methylations occurred in 46% of the Angelman Syndrome ART 
children versus 5% in the general population. The ART children 
with Silver-Russel Syndrome were observed to have 92% of the 
H19 hypomethylations while only 40% of the general population 
had these defects (White et al., 2015). Some researchers ponder 
whether the prolonged exposure to a culture medium plays a role 
in development of these imprinting methylation errors (Davies et 
al., 2012). Day 3 embryos as well as blastocyst embryos were 
studied to determine if time spent in the media culture relates to 
an increase in methylation errors. It was noted that 76% of the 
day 3 embryos, and 50% of the blastocysts, exhibited defects in 
imprinting methylations (White et al., 2015). This report demon-
strated that the extent of time spent in the culture does not pose 
a greater risk for the imprinting errors to occur. Multiple studies 
show that media culture does not significantly affect the outcome 
of IVF, and therefore does not play a role in the increased risk for 
birth defects. 
The absence of natural reproductive fluids in early embryonic 
development has shown to influence the outcomes of gene ex-
pression in the embryo. Downregulation of embryonic nutrition-
al elements and upregulation of apoptosis factors in the oviduct, 
have been seen with the absence of seminal fluid (Bromfeild et 
al., 2014) In mice studies, seminal fluid has been shown to influ-
ence fetal development by inducing immune responses from the 
female reproductive tract. The production of T-regulatory cells 
which act as a protection to the embryo is activated by sem-
inal fluid.  T-regulatory cells are programmed to recognize the 
male antigens present and to suppress inflammation that would 
normally occur with an unidentified antigen. This aids in the ad-
aptation of the uterus required for implantation and placental 
development. Mice studies have shown that with the absence 
of seminal fluid, fetal development, phenotype, and metabolic 
function are altered (Schjenken & Robertson, 2015). Follicular 
fluids have also been shown to influence embryo development. 
A study was done to detect methylation levels in pig blastocysts 
to show differences between fluids present in IVF and natural 
embryos. Whole-genome DNA sequencing was performed for 
methylation analysis. The addition of reproductive fluids into the 
culture for IVF produced embryos of higher quality that were 
similar to embryos produced in vivo. The methylation patterns 
were closer to the methylation of naturally produced embryos. 
Additionally, fewer irregularities in genes involved in imprint-
ing, development, and reprogramming, were noticed in the IVF 
culture that included reproductive fluids (Canovas et al., 2017).
Globally it has been proven through multiple studies that the 
culture medium does not play a role in the increased risk for 
birth defects. Reports on the amount of time spent in the cul-
ture and the culture conditions were analyzed and no increase 
in congenital anomalies was seen. There is a slight association 
between improved gene expression and addition of natural re-
productive fluids to the culture. 
Alternative Treatments
For couples who are having difficulty with conception, espe-
cially at advanced maternal age, the ideal approach is uncertain. 
Infertile couples have a 2 to 12% chance per year of becoming 
pregnant spontaneously. Alternative treatments include but are 
not limited to intrauterine insemination and ovulation induc-
tion. These treatments are less costly than IVF however the 
success rates are well below those of IVF. During intrauterine 
insemination, semen is condensed in a laboratory and then in-
jected past the cervix into the uterus (Van Vorhis & Bradley, 
2007). Ovulation induction involves use of Clomiphene Citrate 
to stimulate follicles and hence egg growth. Clomiphene citrate 
works to increase estrogen levels which then signals the an-
terior pituitary gland to release Luteinizing Hormone which 
stimulates ovulation. Ovulation induction is most often used in 
women with Polycystic Ovarian Syndrome which is the most 
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common cause of anovulatory infertility. Multiple studies found 
links between use of ovulation induction medications and an 
increase in birth defects such as neural tube and cardiac defects. 
This was reportedly due to the fact that these medications are 
given to PCOS patients who often struggle with obesity (Balen 
& Rutherford, 2007). One study suggests an association be-
tween use of clomiphene citrate and craniosynostosis (Reefhuis 
et al., 2003). This is likely due to the multiple births that are 
expected with ovulation induction. Multiples are at increased 
risk for mortality and long term consequences such as congen-
ital anomalies and developmental delays (Corchia et al., 1996). 
The use of prefertilization and preimplantation genetic di-
agnoses combined with IVF significantly increases the rates of 
successful pregnancies. With advanced maternal age, egg quality 
is reduced resulting from abnormalities in the spindle formation 
of the chromosomes. Eggs enter prophase 1 in the first meiotic 
division during the fetal period, and remain in that phase until 
ovulation. When meiosis resumes many years later, the spindle 
formation can be disturbed, leading to a failure to fertilize, abnor-
mal embryo development, and fetal loss (Van Vorhis & Bradley, 
2007). Genetic diagnosis of oocytes, also known as polar body 
analyses, is useful to differentiate between mutations in genetic 
material of the oocyte. Each polar body contains complemen-
tary genetic material to the oocyte. This can reveal any genetic 
alterations of the oocyte which would then be excluded from 
use in IVF. The procedure incorporates, laser microdissection of 
the zona pellucida with a UV-A laser, and extraction of the polar 
body with a micropipette (Clement-Sengewald et al., 2000). After 
genetically normal oocytes are recognized by polar body analy-
ses, they are fertilized and cultured until either day 3 embryos 
or blastocyst stage when they can then be transferred into the 
uterus. Polar body analyses are only useful to detect problems 
with maternal genes. Therefore, another technique known as 
preimplantation genetic diagnosis in commonly used to select 
embryos for transfer using genetic analysis that is performed on 
cells biopsied from embryos. The procedure normally does not 
affect embryo development because the cells at this stage are 
totipotent. The practice allows for a choice of embryos that are 
unaffected by the heritable condition or chromosomal mutations 
prior to pregnancy and thus avoiding termination of pregnancy 
(SenGupta & Delhanty, 2012). 
Conclusion
Multiple studies show a clear association between the use of 
IVF and an increase in birth defects. The research discussed 
above was done to determine whether certain techniques in-
volved in IVF are related to the risk. In multiple studies, cryo-
preservation of oocytes and embryos was not seen to increase 
the risk for birth defects or intellectual disabilities. It was noted 
however, to increase the live birth rate. The various culture 
conditions were examined and they were noted to have slightly 
different effects on transcription but no overall effect on the 
risk for birth defects. Many reports are limited due to the eth-
ical and practical difficulties that are involved while studying 
topics such as human embryonic development. Birth defects 
are rare and thus the observational results were done on small 
sample sizes. Larger studies are required to give a definite an-
swer to the underlying cause of the association. A number of 
studies indicated that the infertility problems of the couples 
undergoing IVF are a likely answer for the increase in congenital 
anomalies. ICSI has also been thought to increase birth defects 
because of the increase in chromosomal abnormalities in men 
with low sperm counts. There is an association between IVF 
and Imprinting Disorders, however the underlying cause is 
not known. The generally older age of patients undergoing IVF 
adds to the plausible complications such as implantation fail-
ure, miscarriage, congenital anomalies, and fetal death. Some of 
these problems can be addressed with Preimplantation Genetic 
Screening (PGS) which screens for embryos with chromosomal 
abnormalities or Preimplantation Genetic Diagnosis (PGD) to 
search for a specific genetic disease. Overall, the comprehensive 
data related to children born from IVF shows that majority are 
not born with birth defects. The risk is greatly reduced when 
IVF is used together with PGD and PGS. Couples considering 
IVF should discuss genetic testing options with their doctor to 
determine if this service is appropriate for their situation.
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